Randomised controlled trial and economic evaluation of home-based medication and lifestyle review by community pharmacists for patients with heart failure

ISRCTN ISRCTN59427925
DOI https://doi.org/10.1186/ISRCTN59427925
Secondary identifying numbers PG/02/171
Submission date
07/09/2005
Registration date
13/09/2005
Last edited
26/04/2007
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Richard Holland
Scientific

School of Medicine
Health Policy & Practice
University of East Anglia
Norwich
NR4 7TJ
United Kingdom

Phone +44 (0)1603 593574
Email r.holland@uea.ac.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeNot Specified
Scientific title
Study acronymHeartMed
Study objectivesThat home-based medication and lifestyle review by community pharmacists can reduce hospital re-admissions in heart failure patients and improve quality of life.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedHeart Failure
InterventionHome-based medication review and lifestyle advice by community pharmacists
Intervention typeOther
Primary outcome measureTotal number of emergency hospital readmissions at six months
Secondary outcome measures1. Total deaths at six months
2. Total heart failure hospital readmissions at six months
3. Self-assessed quality of life at six months using the EQ-5D and Minnesota living with heart failure questionnaire

Also:
1. Admissions to residential or nursing homes at six months
2. Self-assessed compliance at six months using the Medication Adherence Report scale
3. Self-assessed behaviour change at six months using the European heart failure self-care behaviour scale
Overall study start date01/10/2003
Completion date30/04/2006

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participants306
Key inclusion criteria1. Adult (over 18 years)
2. Discharged to home or warden controlled accommodation after an emergency admission in the last month with a primary clinical diagnosis of heart failure
3. Prescribed two or more drugs (oral or inhaled) taken on at least a daily basis
4. Norfolk or Suffolk resident
Key exclusion criteria1. Patients living in residential, nursing homes or long-stay hospitals
2. All patients whose treatment includes planned surgery for ischaemic or valvular heart disease or awaiting heart transplantation
3. All patients with concomitant terminal malignancy.
Date of first enrolment01/10/2003
Date of final enrolment30/04/2006

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

School of Medicine
Norwich
NR4 7TJ
United Kingdom

Sponsor information

University of East Anglia (UK)
University/education

University of East Anglia
Norwich
NR4 7TJ
England
United Kingdom

Phone +44 (0)1603 591486
Email l.briggs@uea.ac.uk
Website http://www.uea.ac.uk/business
ROR logo "ROR" https://ror.org/026k5mg93

Funders

Funder type

Charity

British Heart Foundation (UK)
Private sector organisation / Trusts, charities, foundations (both public and private)
Alternative name(s)
the_bhf, The British Heart Foundation, BHF
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article Results 26/05/2007 Yes No